Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) EBT (2016 - 2025)

Medifast (MED) has disclosed EBT for 16 consecutive years, with -$6.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 600.94% year-over-year to -$6.4 million, compared with a TTM value of -$5.6 million through Dec 2025, down 248.9%, and an annual FY2025 reading of -$5.6 million, down 248.9% over the prior year.
  • EBT was -$6.4 million for Q4 2025 at Medifast, down from -$2.7 million in the prior quarter.
  • Across five years, EBT topped out at $61.3 million in Q2 2021 and bottomed at -$10.6 million in Q2 2024.
  • Average EBT over 5 years is $26.4 million, with a median of $29.5 million recorded in 2022.
  • Peak annual rise in EBT hit 127.0% in 2025, while the deepest fall reached 600.94% in 2025.
  • Year by year, EBT stood at $46.8 million in 2021, then tumbled by 30.68% to $32.4 million in 2022, then tumbled by 69.76% to $9.8 million in 2023, then plummeted by 87.0% to $1.3 million in 2024, then plummeted by 600.94% to -$6.4 million in 2025.
  • Business Quant data shows EBT for MED at -$6.4 million in Q4 2025, -$2.7 million in Q3 2025, and $2.9 million in Q2 2025.